Clinical Trial Update: A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for BPI-361175 in advanced solid tumors, including non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BPI-361175

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN